This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovative Journey of Katalin Goldschmidt nee Horvath
Introduction
Katalin Goldschmidt nee Horvath is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on benzodiazepine derivatives. With one patent to her name, she has demonstrated her commitment to advancing therapeutic treatments that offer valuable benefits to patients.
Latest Patents
Katalin Goldschmidt holds a patent for a novel compound known as the 5H-benzodiazepin derivative. This invention relates specifically to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine and its pharmaceutically acceptable acid addition salts. The patent outlines a process for preparing these compounds, which are noted for their anxiolytic, antiaggressive, and antidepressant effects. Moreover, the compounds have favorable acute toxicity values, making them advantageous for therapeutic applications.
Career Highlights
Throughout her career, Katalin has worked at Egis Gyógyszergyár, a well-known pharmaceutical manufacturer in Hungary. Her work in this leading company has allowed her to bring her innovative ideas to fruition, contributing to the development of new therapies aimed at improving mental health and well-being.
Collaborations
Katalin Goldschmidt has collaborated with several colleagues, including Ferenc Andrasi and Peter Botka. These partnerships highlight the importance of teamwork in the field of innovation and showcase the collective efforts needed to bring groundbreaking ideas to life.
Conclusion
Katalin Goldschmidt nee Horvath's contributions to the pharmaceutical industry through her innovative inventions underscore her dedication to improving therapeutic outcomes. Her patented work on benzodiazepine derivatives not only reflects her ingenuity but also her commitment to enhancing patient care in the realm of mental health. With a strong foundation in research and collaboration, Katalin continues to inspire future innovations in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile